Rapid Nutrition PLC (ALRPD.PA)
EUR 0.04
(0.92%)
EUR 0.04
(0.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.01 Million AUD | 14.52% |
| 2022 | -2.35 Million AUD | -636.9% |
| 2021 | 439.12 Thousand AUD | 214.29% |
| 2020 | -384.23 Thousand AUD | 0.0% |
| 2018 | 1.01 Million AUD | -48.04% |
| 2017 | 1.96 Million GBP | 275.87% |
| 2016 | 521.78 Thousand GBP | -63.82% |
| 2015 | 1.44 Million GBP | 24.0% |
| 2014 | 1.16 Million GBP | 215.38% |
| 2013 | 368.8 Thousand GBP | 183.04% |
| 2012 | -444.15 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -379.05 Thousand AUD | 0.0% |
| 2023 Q4 | -628.64 Thousand AUD | 0.0% |
| 2023 Q1 | -379.05 Thousand AUD | 92.98% |
| 2023 FY | -2.01 Million AUD | 14.52% |
| 2023 Q3 | -628.64 Thousand AUD | -65.85% |
| 2022 Q1 | 544.38 Thousand AUD | 1281.92% |
| 2022 Q4 | -5.4 Million AUD | 0.0% |
| 2022 Q3 | -5.4 Million AUD | -1092.32% |
| 2022 Q2 | 544.38 Thousand AUD | -0.0% |
| 2022 FY | -2.35 Million AUD | -636.9% |
| 2021 Q1 | 180.17 Thousand AUD | 0.0% |
| 2021 Q3 | 39.39 Thousand AUD | -78.14% |
| 2021 Q4 | 39.39 Thousand AUD | 0.0% |
| 2021 Q2 | 180.17 Thousand AUD | -0.0% |
| 2021 FY | 439.12 Thousand AUD | 214.29% |
| 2020 FY | -384.23 Thousand AUD | 0.0% |
| 2019 Q4 | 202.2 Thousand AUD | 0.0% |
| 2019 Q2 | 418.62 Thousand AUD | 0.0% |
| 2019 Q1 | 418.62 Thousand AUD | 360.47% |
| 2019 Q3 | 202.2 Thousand AUD | -51.7% |
| 2018 Q4 | 90.91 Thousand AUD | -0.0% |
| 2018 Q3 | 90.91 Thousand AUD | -87.94% |
| 2018 FY | 1.01 Million AUD | -48.04% |
| 2018 Q2 | 753.65 Thousand AUD | -8.8% |
| 2018 Q1 | 826.33 Thousand AUD | 384.69% |
| 2017 Q1 | -49.19 Thousand AUD | -116.3% |
| 2017 Q3 | 168.34 Thousand AUD | 431.15% |
| 2017 Q4 | 170.48 Thousand AUD | 1.27% |
| 2017 Q2 | -50.83 Thousand AUD | -3.34% |
| 2017 FY | 1.96 Million GBP | 275.87% |
| 2016 Q1 | 283.56 Thousand AUD | 11.22% |
| 2016 Q3 | 301.81 Thousand AUD | 99.88% |
| 2016 Q4 | 301.81 Thousand AUD | 0.0% |
| 2016 Q2 | 151 Thousand AUD | -46.75% |
| 2016 FY | 521.78 Thousand GBP | -63.82% |
| 2015 FY | 1.44 Million GBP | 24.0% |
| 2015 Q4 | 254.95 Thousand AUD | 0.0% |
| 2015 Q3 | 254.95 Thousand AUD | 105.82% |
| 2015 Q2 | 123.87 Thousand AUD | 0.0% |
| 2015 Q1 | 123.87 Thousand AUD | -72.93% |
| 2014 Q3 | 457.68 Thousand AUD | 218.96% |
| 2014 FY | 1.16 Million GBP | 215.38% |
| 2014 Q4 | 457.68 Thousand AUD | 0.0% |
| 2014 Q2 | -384.72 Thousand AUD | 0.0% |
| 2013 Q2 | -372.19 Thousand AUD | 0.0% |
| 2013 FY | 368.8 Thousand GBP | 183.04% |
| 2012 FY | -444.15 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AB Science S.A. | -13.42 Million EUR | 84.992% |
| Boiron SA | 42.29 Million EUR | 104.766% |
| Fagron NV | 105.44 Million EUR | 101.911% |
| Ipsen S.A. | 816 Million EUR | 100.247% |
| Malin Corporation plc | -4.5 Million EUR | 55.213% |
| Vetoquinol SA | 74.26 Million EUR | 102.714% |